As a global leader in medical technology, services and solutions, Medtronic improves the health and lives of millions of people each year. We believe our deep clinical, therapeutic and economic expertise can help address the complex challenges — such as rising costs, aging populations and the burden of chronic disease — faced by families and healthcare systems today. But, we can’t do it alone. That’s why we’re committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes.
Founded in 1949 as a medical repair company, we're now among the world's largest medical technology, services and solutions companies, employing more than 85,000 people worldwide, serving physicians, hospitals and patients in more than 160 countries. Join us in our commitment to take healthcare Further, Together. Learn more at Medtronic.com.
MicroVention provides a complete 360-degree approach to developing neuroendovascular technologies and currently consists of four main product groups: Aneurysm Therapy Solutions, Ischemic Stroke and Carotid Artery Disease Solutions, Neurovascular Malformation Solutions, and Access Products. Additionally, our extensive product lines in each category allow our customers to uniquely address and customize the needs of their patients for many types of situations. We have a long track record of innovation and industry firsts and know that our success is built solely on the partnerships with our customers who share our passion for innovation and technology. For MicroVention this means being a reliable and agile partner and providing our customers the finest technology available for their patients. Looking toward the future, we are committed to excellence in everything we do, and we strive to continually improve and innovate. We are dedicated to achieving results that exceed expectations -our own and our customers’.
For more information call or 1-800-990-8368.
Aliso Viejo, CA 92656
Phone: (714) 247-8000
Email: [email protected]
We are focused on advancing the practice of less invasive stroke therapies through our Complete Stroke Care solutions. We are dedicated to providing innovative stroke products and services for ischemic and hemorrhagic stroke, and committed to providing clinical education and support to help physicians deliver better patient outcomes.
CERENOVUS, part of Johnson & Johnson Medical Devices Companies, is a global leader in neurovascular care. Our commitment to changing the trajectory of stroke is inspired by our long heritage and dedication to helping physicians protect people from a lifetime of hardship. CERENOVUS offers a broad portfolio of devices used in the endovascular treatment of hemorrhagic and ischemic stroke. For more information, visit www.cerenovus.com.
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets innovative products and has a broad portfolio that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and vascular.
Since its founding in 2005, phenox has been dedicated to developing innovative, breakthrough and clinically proven technologies and solutions for the treatment of neurovascular diseases. phenox's products are used by endovascular specialists to treat ischemic and hemorrhagic stroke. The company offers a growing portfolio of innovative treatment options, including the primary interventional technologies used today. The product range includes devices for mechanical thrombectomy as well as Flow Diverters for aneurysm treatment.